Page 97 - Read Online

Sulaiman et al. J Transl Genet Genom 2020;4:159-87 I https://doi.org/10.20517/jtgg.2020.27 Page 183

cytochrome b gene. Eur J Hum Genet 2001;9:510-8.
98. Keightley JA, Anitori R, Burton MD, Quan F, Buist NR, et al. Mitochondrial encephalomyopathy and complex III deficiency associated
with a stop-codon mutation in the cytochrome b gene. Am J Hum Genet 2000;67:1400-10.
99. Tarnopolsky MA, Simon DK, Roy BD, Chorneyko K, Lowther SA, et al. Attenuation of free radical production and paracrystalline
inclusions by creatine supplementation in a patient with a novel cytochrome b mutation. Muscle Nerve 2004;29:537-47.
100. Dumoulin R, Sagnol I, Ferlin T, Bozon D, Stepien G, et al. A novel gly290asp mitochondrial cytochrome b mutation linked to a complex
III deficiency in progressive exercise intolerance. Mol Cell Probes 1996;10:389-91.
101. Andreu AL, Bruno C, Shanske S, Shtilbans A, Hirano M, et al. Missense mutation in the mtDNA cytochrome b gene in a patient with
myopathy. Neurology 1998;51:1444-7.
102. Pulkes T, Liolitsa D, Nelson IP, Hanna MG. Classical mitochondrial phenotypes without mtDNA mutations: the possible role of nuclear
genes. Neurology 2003;61:1144-7.
103. Karadimas CL, Greenstein P, Sue CM, Joseph JT, Tanji K, et al. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene
of mitochondrial DNA. Neurology 2000;55:644-9.
104. Kollberg G, Moslemi AR, Lindberg C, Holme E, Oldfors A. Mitochondrial myopathy and rhabdomyolysis associated with a novel
nonsense mutation in the gene encoding cytochrome c oxidase subunit I. J Neuropathol Exp Neurol 2005;64:123-8.
105. Rahman S, Taanman JW, Cooper JM, Nelson I, Hargreaves I, et al. A missense mutation of cytochrome oxidase subunit II causes
defective assembly and myopathy. Am J Hum Genet 1999;65:1030-9.
106. McFarland R, Taylor RW, Chinnery PF, Howell N, Turnbull DM. A novel sporadic mutation in cytochrome c oxidase subunit II as a cause
of rhabdomyolysis. Neuromuscul Disord 2004;14:162-6.
107. Kennaway NG, Burton MD, Hall RE, Johnston WSW, Keightley JA, et al. Mitochondrial myopathy and cytochrome c oxidase (COX)
deficiency associated with a 15 bp deletion in the gene for COX subunit III. (Abstract 827)” Neurology 1994;44:A335.
108. Musumeci O, Andreu AL, Shanske S, Bresolin N, Comi GP, et al. Intragenic inversion of mtDNA: a new type of pathogenic mutation in a
patient with mitochondrial myopathy. Am J hum genet 2000;66:1900-4.
109. Valnot I, Kassis J, Chretien D, de Lonlay P, Parfait B, et al. A mitochondrial cytochrome b mutation but no mutations of nuclearly
encoded subunits in ubiquinol cytochrome c reductase (complex III) deficiency. Human genetics 1999;104:460-6.
110. Andreu AL, Checcarelli N, Iwata S, Shanske S, DiMauro S. A missense mutation in the mitochondrial cytochrome b gene in a revisited
case with histiocytoid cardiomyopathy. Pediatr Res 2000;48:311-4.
111. Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, et al. Heteroplasmic point mutations of mitochondrial DNA affecting
subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood 1997;90:4961-72.
112. Pandya A, Xia XJ, Erdenetungalag R, Amendola M, Landa B, et al. Heterogenous point mutations in the mitochondrial tRNA Ser(UCN)
precursor coexisting with the A1555G mutation in deaf students from Mongolia. Am J Hum Genet 1999;65:1803-6.
113. Wang Q, Li R, Zhao H, Peters JL, Liu Q, et al. Clinical and molecular characterization of a Chinese patient with auditory neuropathy
associated with mitochondrial 12S rRNA T1095C mutation. Am J Med Genet A 2005;133A:27-30.
114. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, et al. Mitochondrial DNA variants observed in Alzheimer disease and
Parkinson disease patients. Genomics 1993;17:171-84.
115. Kosel S, Egensperger R, Mehraein P, Graeber MB. No association of mutations at nucleotide 5460 of mitochondrial NADH
dehydrogenase with Alzheimer’s disease. Biochem Biophys Res Commun 1994;203:745-9.
116. Lin FH, Lin R, Wisniewski HM, Hwang YW, Grundke-Iqbal I, et al. Detection of point mutations in codon 331 of mitochondrial NADH
dehydrogenase subunit 2 in Alzheimer’s brains. Biochem Biophys Res Commun 1992;182:238-46.
117. Petruzzella V, Chen X, Schon EA. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer’s disease. Biochem
Biophys Res Commun 1992;186:491-7.
118. Online Mendelian Inheritance in Man O. Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic
Medicine. Baltimore, MD: Johns Hopkins University; 2019.
119. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 2010;11:872-84.
120. Geto Z, Molla MD, Challa F, Belay Y, Getahun T. Mitochondrial dynamic dysfunction as a main triggering factor for inflammation
associated chronic non-communicable diseases. J Inflamm Res 2020;13:97-107.
121. Niyazov DM, Kahler SG, Frye RE. Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction
for diagnosis and treatment. Mol Syndromol 2016;7:122-37.
122. Morava E, van den Heuvel L, Hol F, de Vries MC, Hogeveen M, et al. Mitochondrial disease criteria: Diagnostic applications in children.
Neurology 2006;67:1823-6.
123. Bris C, Goudenege D, Desquiret-Dumas V, Charif M, Colin E, et al. Bioinformatics Tools and Databases to Assess the Pathogenicity of
Mitochondrial DNA Variants in the Field of Next Generation Sequencing. Front Genet 2018;9:632.
124. Xu J, Kitada M, Koya D. The impact of mitochondrial quality control by Sirtuins on the treatment of type 2 diabetes and diabetic kidney
disease. Biochim Biophys Acta Mol Basis Dis 2020;1866:165756.
125. Li K, Wu L, Liu J, Lin W, Qi Q, et al. Maternally inherited diabetes mellitus associated with a Novel m.15897G>A mutation in
mitochondrial tRNA(Thr) gene. J Diabetes Res 2020;2020:2057187.
126. Sangwung P, Petersen KF, Shulman GI, Knowles JW. Mitochondrial dysfunction, insulin resistance and potential genetic implications.
Endocrinology 2020; doi: 10.1210/endocr/bqaa017.
127. Pereira CA, Carlos D, Ferreira NS, Silva JF, Zanotto CZ, et al. Mitochondrial DNA promotes NLRP3 inflammasome activation and
contributes to endothelial dysfunction and inflammation in Type 1 diabetes. Front Physiol 2020;10:1557.